首页/数据集/Crystal Structure of SARS-CoV-2 Mpro S10A in complex with Pfizer Intravenous Inhibitor PF-00835231

Crystal Structure of SARS-CoV-2 Mpro S10A in complex with Pfizer Intravenous Inhibitor PF-00835231

NIAID Data Ecosystem2026-05-10 收录

SARS-CoV-2主蛋白酶-抑制剂复合物结构

抗新冠病毒药物研发

数据链接：

https://www.rcsb.org/structure/9O6D 数据链接链接失效反馈

官方服务：

资源简介：

Crystal Structure of SARS-CoV-2 Mpro S10A in complex with Pfizer Intravenous Inhibitor PF-00835231

应用场景：

创建时间：

2026-01-28

抗新冠病毒药物研发

蛋白酶抑制剂设计

Crystal Structure of uncleaved SARS-CoV-2 Main Protease C145S mutant in complex with Nirmatrelvir

NIAID Data Ecosystem60

Structure of SARS-Cov2 3CLPro in complex with Compound 34

抗新冠病毒药物研发

3CL蛋白酶抑制剂

Structure of SARS-Cov2 3CLPro in complex with Compound 34 Descriptor: 3C-like proteinase nsp5, methyl {(2S)-1-[(1S,3aR,6aS)-1-{[(2R,3S,6S)-6-fluoro-2-hydroxy-1-(methylamino)-1-oxoheptan-3-yl]carbamoyl

Protein Data Bank Japan2024-10-23 更新20

SARS-CoV2 major protease in covalent complex with a soluble inhibitor.

抗新冠病毒药物研发

蛋白酶抑制剂设计

SARS-CoV2 major protease in covalent complex with a soluble inhibitor.

NIAID Data Ecosystem10

SARS-CoV-2 NSP14 inhibitor exhibits potent antiviral activity and reverses NSP14-driven host modulation

抗新冠病毒药物研发

病毒甲基转移酶抑制剂

The emergence of SARS-CoV-2 variants and drug-resistant mutants underscores the urgent need for novel antiviral therapeutics. SARS-CoV-2 NSP14, an N7-guanosine methyltransferase, plays a critical role

NIAID Data Ecosystem60

An Antiviral Formulation with DNA Gyrase and RNA Dependent RNA Polymerase Suppressive Features As an Adjunct Treatment for Coronaviral Infections

抗新冠病毒药物研发

RNA聚合酶抑制剂

A Combination of Protopanaxatriol Class Antiviral Glucopyranoside Analogues may serve as potent antiviral agents due to their RNA Dependent RNA Polymerase Suppressive and indirect Immunostimulant Acti

NIAID Data Ecosystem10

Crystal Structure of SARS-CoV-2 Mpro S10A in complex with Pfizer Intravenous Inhibitor PF-00835231

资源简介：

相关数据集